Skip to content

As U.S. Slashes $500M in mRNA Funding, Bordeaux Biotech bYoRNA Raises €1.5M to Reinvent RNA Production

bYoRNA is developing a patented fermentation process that could cut RNA production costs by 100x, improve safety, and enable global access to next-generation vaccines and therapies. This breakthrough comes as the U.S. is rejecting mRNA, a move that complicates the startup's business strategy.

The bYoRNA team

This post is for paying subscribers only

Subscribe

Already have an account? Sign In

Latest

🐇 Follow Me Down The Voice AI Rabbit Hole 🎤
AI

🐇 Follow Me Down The Voice AI Rabbit Hole 🎤

Voice AI has crossed the uncanny valley, turning sound, speech, and music into powerful tools. It’s fun, unsettling, and wildly investable. Welcome to the hottest, weirdest market in AI, where France is making some noise.

Members Public